|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
109.12(B) |
Last
Volume: |
5,365,633 |
Avg
Vol: |
8,385,378 |
52
Week Range: |
$48.64 - $77.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
304,513 |
503,645 |
1,002,990 |
2,126,174 |
Total Sell Value |
$22,679,618 |
$34,760,114 |
$61,125,774 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
26 |
44 |
80 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Phalen Michael P. |
SVP & President, Endoscopy |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,274 |
22,586 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-12 |
4 |
D |
$7.39 |
$12,659 |
D/D |
(1,713) |
21,943 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
23,656 |
|
- |
|
Pedersen John B. |
Pres,Uro & Womens Health |
|
2010-02-12 |
4 |
D |
$7.39 |
$2,801 |
D/D |
(379) |
619 |
|
- |
|
Pedersen John B. |
Pres,Uro & Womens Health |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
998 |
998 |
|
- |
|
Leno Sam R |
CFO & EVP Finance & IS |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,982 |
227,464 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-12 |
4 |
D |
$7.39 |
$25,362 |
D/D |
(3,432) |
37,700 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,806 |
41,132 |
|
- |
|
Paul Donovan |
SVP, Corporate Communications |
|
2010-02-12 |
4 |
D |
$7.39 |
$24,424 |
D/D |
(3,305) |
33,103 |
|
- |
|
Paul Donovan |
SVP, Corporate Communications |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,406 |
36,408 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-12 |
4 |
D |
$7.39 |
$5,742 |
D/D |
(777) |
30,465 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,996 |
31,242 |
|
- |
|
Moreci Stephen F |
SVP, Global Sales Operations |
|
2010-02-12 |
4 |
D |
$7.39 |
$8,402 |
D/D |
(1,137) |
21,177 |
|
- |
|
Moreci Stephen F |
SVP, Global Sales Operations |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,995 |
22,314 |
|
- |
|
Colen Fred |
EVP & Chief Technology Officer |
|
2010-02-12 |
4 |
D |
$7.39 |
$48,966 |
D/D |
(6,626) |
62,815 |
|
- |
|
Colen Fred |
EVP & Chief Technology Officer |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,468 |
69,441 |
|
- |
|
Kucheman William |
EVP, Cardiology |
|
2010-02-12 |
4 |
D |
$7.39 |
$19,310 |
D/D |
(2,613) |
42,366 |
|
- |
|
Kucheman William |
EVP, Cardiology |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,986 |
44,979 |
|
- |
|
Gilbert James |
EVP, Strategy & Business Dev |
|
2010-02-12 |
4 |
D |
$7.39 |
$11,203 |
D/D |
(1,516) |
65,393 |
|
- |
|
Gilbert James |
EVP, Strategy & Business Dev |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
66,909 |
|
- |
|
Pucel Kenneth |
EVP, Global Operations |
|
2010-02-12 |
4 |
D |
$7.39 |
$30,927 |
D/D |
(4,185) |
59,485 |
|
- |
|
Pucel Kenneth |
EVP, Global Operations |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,178 |
63,670 |
|
- |
|
Lance Jean Fitterer |
Chief Compliance Officer |
|
2010-02-12 |
4 |
D |
$7.39 |
$9,186 |
D/D |
(1,243) |
50,068 |
|
- |
|
Lance Jean Fitterer |
Chief Compliance Officer |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,194 |
51,311 |
|
- |
|
Mcfaul David W |
SVP, International |
|
2010-02-12 |
4 |
D |
$7.39 |
$7,841 |
D/D |
(1,061) |
41,426 |
|
- |
|
1824 Records found
|
|
Page 45 of 73 |
|
|